PROCEPT BioRobotics Focuses on Growth of Aquablation Devices for BPH Treatment
- Published
- Source
- Seekingalpha.com
PROCEPT BioRobotics Corporation (PRCT) is advancing its Aquablation devices designed for urology, specifically targeting benign prostatic hyperplasia (BPH). These innovative devices provide patients with enduring relief from urinary symptoms while minimizing the side effects commonly associated with traditional treatments.
The significance of PROCEPT BioRobotics' efforts lies in the potential for Aquablation to transform BPH management. By offering a less invasive option, the company aims to improve patient outcomes and satisfaction, which is crucial in a market where effective treatment options are in high demand.
Looking ahead, it will be important to monitor the adoption rates of Aquablation devices and any developments in clinical outcomes. No further timeline was disclosed at the time of publication.
Original report
PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth
Seekingalpha.comThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
-
9
SRS 2027 – Rome, Jun 23–27, 2027 RobotToday · 1 week ago
- 10
- 11
- 12
Related Suppliers
PROCEPT BioRobotics
United States
San Jose surgical robotics company commercializing the AQUABEAM Robotic System, an FDA-cleared automated robot for BPH via heat-free waterjet ablation.
Andromeda Surgical
United States
South San Francisco startup developing AI-powered autonomous surgical robots for endourology, starting with robotic HoLEP for benign prostatic hyperplasia.
Boston Scientific
United States
Marlborough, Massachusetts medical device maker founded 1979; NYSE-listed (BSX) manufacturer of minimally invasive interventional devices.
Richard Wolf GmbH
Germany
Knittlingen Germany endoscopy instrument maker since 1906; rigid/flexible scopes, imaging systems, shockwave therapy; 1,700 staff, 20 subsidiaries worldwide.
Ganymed Robotics
France
Ganymed Robotics is a Paris-based medtech startup developing a marker-less, co-manipulated robotic assistant for total knee arthroplasty.
MRI Robotics LLC
United States
US developer of MRI-compatible robotic systems for image-guided surgical interventions inside MRI scanners.
Sagebot Intelligent Medical 哈尔滨思哲睿智能医疗设备股份有限公司
China
Harbin-based Sagebot makes the Kando multi-arm laparoscopic surgical robot, NMPA-approved for urology in 2022, and is pursuing a STAR Market IPO.
Cornerstone Robotics
Hong Kong
Hong Kong surgical robotics firm whose Sentire endoscopic system holds CE Mark, Singapore HSA and China NMPA clearance for minimally invasive surgery.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
